Trial Details

COMPLETED
Basic Information
Clinical ID c793
Identifier NCT01517607
Trial Title Mesalazine (PENTASA) in Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions OTHER: Mesalazine
Participant Information
Sponsor Ferring Pharmaceuticals
City Altenburg
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2025-02-12
Primary Completion Date 2025-12-13
Completion Date 2025-12-13